JAK Inhibitors, Biologics, and Phosphodiesterase-4 Inhibitors for the Management of Alopecia Areata in Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors
J Eur Acad Dermatol Venereol 2022 Dec 07;[EPub Ahead of Print], AK Gupta, T Wang, S Polla Ravi, MA Bamimore, V Piguet, A TostiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.